Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases
Activation of the chemokine receptor CCR6 orchestrates the trafficking of IL-17-producing pathogenic immune cells to the sites of inflammation, thus contributing to the development of numerous inflammatory and autoimmune diseases. As such, CCR6 has eme…